Biogen

Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week's bullish calls included picks from Gene Munster and the maker of a potentially blockbuster Alzheimer's treatment. Software and leisure apparel giants, as well as the most popular...

The cover story in this weekend's Barron's examines how teenage traders are shaking up the market. Other featured articles discuss which drugmakers benefit from a new market, why it is time to buy momentum stocks and how to safely hunt for yield. Also, see the prospects for a semiconductor...

Benzinga has examined the prospects for many investor favorite stocks over the past week. The past week's bullish calls included the e-commerce leader, a top biotech and the airlines. The iPhone maker, the top cryptocurrency and a COVID-19 vaccine maker were among the bearish calls seen. The...

If you’re reading this, then apparently you weren’t affected by a global internet outage that hit many news websites. The outage appeared to hurt stock futures overnight, but things recovered to flat in the hours right before the open.  Flat might be the word of the day, and maybe...

Major U.S. indices had a mixed day of trading Monday as investors continue to weigh better-than-expected May unemployment rate numbers from last Friday. The SPDR S&P 500 ETF Trust (NYSE: SPY) closed slightly lower by 0.097% to $422.19. The SPDR Dow Jones...

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Some insiders have taken advantage of recent biotech initial public offerings. Some chief executives also stepped up to the buy window this past week. Conventional wisdom says that...

This weekend's Barron's cover story discusses a coming Alzheimer's crisis. Other featured articles discuss whether utilities are worth another look, which real estate investment trusts to focus on and how to play rising platinum prices. Also, the prospects for a popular trading app...

Insider buying can be an encouraging signal for potential investors when markets face uncertainty. This past week, some insiders added to their stakes in REITs, a specialty retailer and a packaged foods giant. Some insiders were making return trips to the buy window to increase their stakes....

This weekend's Barron's examines how Biden won an extraordinary election and what a Biden administration could mean. Other featured articles discuss how to position a portfolio for political gridlock, the outlook for big tech and dividends that are being resumed. Also, the prospects...

This weekend's Barron's reveals what legendary stock picker Peter Lynch has to say about active investing, growth stocks and more. Other featured articles look at which of the decade's top performers still have room to run and how Barron's 2019 tech stock picks fared. Also, the...

Benzinga has examined the prospects for many investor favorite stocks over the past week. Bullish calls included e-commerce, electric vehicle and semiconductor leaders. Bearish calls included video streaming giant and biotech giants. The first week of December started with a record start to the...

So far, red hasn’t colored October the way it did last year, but the hunt for an elusive 3000 in the S&P 500 Index continues after the market couldn’t get its head above that particular wave last week.  The next five days are packed on the earnings beat, with about a quarter of...

Benzinga has featured looks at many investor favorite stocks over the past week. Bullish calls included a top retailer, a leading pharmaceutical company and a regional bank. Bearish calls featured an industrial giant, a big biotech and an oilfield services provider. Volatility may have...

In the world of exchange traded funds (ETFs), there are funds dedicated to share buybacks and plenty dedicated to dividends. A few ETFs combine both avenues of shareholder rewards. The newest entrant is the aptly named iShares U.S. Dividend and Buyback ETF (CBOE: DIVB). The iShares U.S. Dividend...